Clinical trial
Randomized Cross-Over Evaluation of Medium Cut-Off and High-Flux Hemodialysis Membranes on Inflammation and Cardiovascular Function in Maintenance Hemodialysis Patients
NCT07679763 is registered in ClinicalTrials.gov with Gazi University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Cross-Over Evaluation of Medium Cut-Off and High-Flux Hemodialysis Membranes on Inflammation and Cardiovascular Function in Maintenance Hemodialysis Patients
- Lead sponsor
- Gazi University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 1, 2026
- Completion date
- January 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases (cvd), end stage kidney disease (eskd), hemodialysis, inflammation